A study of HLA-region genes and their products in patients with autoimmune diseases.

自身免疫性疾病患者 HLA 区基因及其产物的研究。

基本信息

  • 批准号:
    03670338
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 1992
  • 项目状态:
    已结题

项目摘要

At least one or several genes in human histocompatibility complex (HLA) play roles on the disease process of autoimmune diseases. In Caucasian, it is well established that individuals carrying HLA-DR3,DQ2 are more susceptible to many autoimmune diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), myasthenia gravis (MG), systemic sclerosis (SSc).In Japanese, however, susceptible gene(s) in the HLA region of diseases listed above are still unclear.I studied HLA specificities by serological method, restriction fragment length polymorphism (RFLP) of genomic DNA, alleles of class II genes by using polymerase chain reaction-RFLP, and complement 4 (C4) allotypes in 86 patients of SLE, 69 of SS, 74 of MG, 33 of SSc and 36 of polymyositis and/or mixed connective tissue disease (PM/MCTD). The results obtained were as follows.1) Among SLE patients, individuals positive for HLA-DR4 are more susceptible to lupus nephritis, but resistant to the involvement of central nervou … More s system than those without DR4. The frequency of the null allele of C4A gene (C4AQ0) is higher in SLE patients than in controls, however, deletion of C4A gene was not detected by RFLP method.2) Higher incidences of HLA-DR53, DPB1*0201 and DQA1*03 were observed in female patients with MG when compared with the controls. The results indicate that Japanese patients with MG can be subdivided into at least two distinct groups. The first group consists of females whose disease onset is early and who have a high frequency of DR53, DPB1*0201 and DQ1*03. The second group consists of males and females with late onset of disease.No particular HLA allele was found to be associated with the second group. Furthermore at least two distinct HLA class II genes were suggested to play roles on the disease onset of young females with MG.3) Among SSc, the frequencies of HLA-DR2, C4BQ0 and anti-Scl 70 antibody were higher in patients with pulmonary fibrosis than those without it. Therefore, careful monitoring and treatment at an early stage of disease may necessary in patients the DR2 and C4BQ0. Less
人组织相容性复合体(HLA)中至少有一个或几个基因参与自身免疫性疾病的发病过程。在白种人中,携带HLA-DR3、DQ2的个体更容易患许多自身免疫性疾病,如系统性红斑狼疮(SLE)、干燥综合征(SS)、重症肌无力(MG)、系统性硬化症(SSc)。然而,在日本,上述疾病HLA区域的易感基因仍不清楚。我对86例SLE患者、69例SS患者、74例MG患者、33例SSc患者和36例多发性肌炎和/或混合性结缔组织病(PM/MCTD)患者采用血清学方法研究HLA特异性、基因组DNA限制性片段长度多态性(RFLP)、II类基因等位基因(RFLP)和补体4 (C4)等位型。所得结果如下:1)在SLE患者中,HLA-DR4阳性个体更容易发生狼疮性肾炎,但对中枢神经系统的累及较无DR4者有抵抗力。SLE患者C4A基因空等位基因(C4AQ0)的频率高于对照组,但RFLP法未检测到C4A基因缺失。2)女性MG患者HLA-DR53、DPB1*0201、DQA1*03的发生率高于对照组。结果表明,日本MG患者可以细分为至少两个不同的群体。第一组为发病早、DR53、DPB1*0201、DQ1*03频率较高的女性。第二组包括发病较晚的男性和女性。没有发现特定的HLA等位基因与第二组相关。此外,至少有两种不同的HLA II类基因在年轻女性mg的发病中发挥作用。3)SSc中,肺纤维化患者的HLA- dr2、C4BQ0和抗scl70抗体的频率高于无SSc的患者。因此,对于DR2和C4BQ0患者,在疾病早期进行仔细的监测和治疗可能是必要的。少

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Horiki T, Moriuchi J, Inoko H, Morita K, Shinohara Y, Ichikawa Y, Arimori S: "HLA-DPB1 allele associates with early-onset myasthenia gravis in Japan."
Horiki T、Moriuchi J、Inoko H、Morita K、Shinohara Y、Ichikawa Y、Arimori S:“HLA-DPB1 等位基因与日本早发性重症肌无力有关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Moriuchi J: "Genetic background of Sjogren's syndrome." Clin Immunol. 24. 363-370 (1992)
Moriuchi J:“干燥综合征的遗传背景。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Morita K: "HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan." Ann Neurol. 29. 164-174 (1991)
Morita K:“日本重症肌无力的 HLA II 类抗原和 DNA 限制性片段长度多态性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horiki T: "HLA-DPB1 allele associates with carly-onset myasthenia gravis in Japan." Neurology. in press.
Horiki T:“HLA-DPB1 等位基因与日本卡利发病重症肌无力有关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horiki T: "HLA-DPBl allele associates with early-onset myasthenia gravis in Japan." Neurology.
Horiki T:“HLA-DPBl 等位基因与日本早发性重症肌无力有关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORIUCHI Junko其他文献

MORIUCHI Junko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORIUCHI Junko', 18)}}的其他基金

Genes in the HLA class III region and their products in patients with rheumatoid arthritis and Sjogren's syndrome.
类风湿关节炎和干燥综合征患者 HLA III 类区域的基因及其产物。
  • 批准号:
    63570301
  • 财政年份:
    1988
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome
探索转录因子 Ets1 在干燥综合征中的作用
  • 批准号:
    10644080
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome
衰老和氧化应激对干燥综合征唾液腺疾病的影响
  • 批准号:
    10682148
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10854472
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
  • 批准号:
    10528045
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Harnessing molecular signatures to deliver personalised B-cell targeted therapies in Sjogren's syndrome
利用分子特征为干燥综合征提供个性化 B 细胞靶向治疗
  • 批准号:
    MR/X004694/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
  • 批准号:
    10646349
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
  • 批准号:
    10524424
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10685136
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
  • 批准号:
    10657745
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10554383
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了